CClinicalTrials.gg
CompletedNCT04966780RLSUpdated Jul 26, 2021

Refeeding Like Syndrome in Acute Disease

An observational study in Refeeding Syndrome and Acute Abdomen, sponsored by Jens Rikardt Andersen. Completed at 1 site in Denmark. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2021-07-26.

Sponsored by Jens Rikardt Andersen · Observational

Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
48
Ages
18 Years and older
Sex
All
01

Study summary

The refeeding syndrome has been reported without any evidence of prolopnged semistarvation, thus being different from the traditional disease.

The investigators wanted to investigate, if sodium infusions could be part of the explanation.

Read the detailed description

Background: Refeeding syndrome is conventionally connected to start of feeding after prolonged periods of semi-starvation and adaption. However, it is also described in acutely ill patients and in ICU patients without a history of adaption, but sometimes only defined as a drop in p-phosphate without clinical manifestations. The investigators hypothesize, that a positive sodium balance could induce the refeeding-like syndrome (RLS).

Method: Consecutive patients for acute, abdominal surgery were included and observed until discharge or up to seven days postoperatively with daily sodium and phosphate balance measurements.

02

Conditions studied

  • Refeeding Syndrome
  • Acute Abdomen

Keywords

  • refeeding syndrome
  • acute abdominal disease
03

In context

Syndrome

9,215 studies on the registry are indexed under Syndrome; 1,029 are open to participants now.

This study's enrollment of 48 is below the median of 102 across 2,209 observational studies indexed under Syndrome.

Browse Syndrome studies →

Lead sponsor

Jens Rikardt Andersen is the lead sponsor of 23 studies on the registry; 1 is open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

Consecutive, adult patients for acute, abdominal surgery were asked top be included and observed until discharge or up to seven days postoperatively with daily sodium and phosphate balance measurements.

Inclusion criteria

  • age > 18 yr
  • ready for acute surgery
  • able to understand and cooperate.

Exclusion criteria

Exclusion Criteria:

  • pregnancy or breastfeeding
  • renal insufficiency (p-creatinine>400 micr mol/l)
  • re-operations
  • expected hospital stay \< 24 hours.
05

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
48 participants (actual)
Patient registry
No

Interventions

  • Procedureacute abdominal surgery

    Acute surgery for acute abdominal disease

06

What researchers measure

Primary outcomes

  1. sodium balance

    correlation between sodium balance and occurrence of the refeeding syndrome

    Time frame: 7 days

Secondary outcomes

  1. plasma phosphate

    correlation between sodium balance and change in plasma phosphate

    Time frame: 7 days

  2. urinary excretion of phosphate

    correletion between sodium balance and urinary excretion of phosphate

    Time frame: 7 days

  3. phosphate balance

    correlation between decline in plasma phosphate and urinary excretion of phosphate

    Time frame: 7 days

07

Study locations

1 site
  • Herlev University Hospital
    Herlev, 2730, Denmark
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jul 26, 2021, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT04966780
Lead sponsor
Jens Rikardt Andersen
Collaborators
University of Copenhagen
Responsible party
Jens Rikardt Andersen (Associate Professor, Primary Investigator, University of Copenhagen) — Sponsor-investigator
First posted
Jul 19, 2021
Start date
Apr 1, 2018
Primary completion
Jun 1, 2021
Completion
Jun 1, 2021
Last update
Jul 26, 2021

Study contacts

jens R Andersen
principal investigator · University of Copenhagen

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Jul 2021. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion